by Joel Lord
20th February 2011 – By Joel Lord
The headlines alone tell the whole story. ‘Teenage girl left brain-damaged after receiving cervical cancer jab‘, ‘Thousands of UK schoolgirls have suffered adverse reactions…several reported multiple reactions’, ‘20,575 adverse reactions, 352 reports of abnormal pap smears post vaccination, 89 reported deaths’, ‘New Worries About Gardasil Safety’, ‘Cervical Cancer Vaccine May Raise Risk of Guillain-Barre Syndrome’, ‘8 more deaths connected to HPV vaccine’…
According to the Centre for Disease Control (CDC), Cervical Cancer is “the 2nd leading cause of cancer deaths among women around the world. In the United States, about 10,000 women get cervical cancer every year and about 4,000 are expected to die from it.”. What the CDC doesn’t tell you is the fact that “70 percent of all HPV infections resolve themselves without treatment within a year. Within two years, the number climbs to 90 percent. Of the remaining 10 percent of HPV infections, only half will develop into cervical cancer, which leaves little need for the vaccine” – the viewpoint of Dr.Diane Harper, lead researcher in the development of two human papilloma virus vaccines, Gardasil and Cervarix, and one seemingly in direct contradiction to the scientific literature being ‘foisted’ on the public by Vaccine Manufacturers Merck (Gardasil) & GlaxoSmithKline (Cervarix); vigorously backed by Government directed Health Departments around the world.
Gardasil ostensibly protects against 4 of the most prevalent genital HPV strains, types 6, 11, 16 & 18; said to account for 70% of cervical cancers & 90% of related genital warts. Given the limitations of Merck’s original clinical trial methods, the fact that malignant cervical cancer takes decades to develop and yet the longest clinical trial on Gardasil was only four years in duration; irrespective of the overwhelming evidence citing a 74% drop in cervical cancer mortality & incidence rates, in developed countries, due to a widespread emphasis on regular pap smears & safe sex and/or abstinence from unprotected sex, the bottom line indicates ‘Gardasil was never shown to prevent cervical cancer.’
In fact, Merck clearly admits, on its official package insert, to the limited effectiveness of its product – ‘GARDASIL has not been demonstrated to protect against diseases due to HPV types not contained in the vaccine. Not all vulvar, vaginal, and anal cancers are caused by HPV, and GARDASIL protects only against those vulvar, vaginal, and anal cancers caused by HPV (Human Papillomavirus).’
The official tally of serious adverse events (ie. Guillain-Barre Syndrome) & deaths resulting from inoculation with Gardasil & Cervarix currently stands at ‘3.34/100,000 doses distributed’, almost double the average death rate from cervical cancer (2.4/100,000 women). The Vaccine Adverse Event Reporting System (VAERS) has confirmed, as of November 3, 2010, a total of 20,575 adverse reactions, including 352 reports of abnormal pap smears post vaccination and 89 reported deaths associated with Gardasil & Cervarix.